^
Association details:
Biomarker:No biomarker
Cancer:Penile Cancer
Drug:carboplatin (Tubulin polymerization promoter) +
paclitaxel (Tubulin inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Treatment...chemotherapy for advanced disease...Paclitaxel in combination with carboplatin may provide an alternative regimen in patients who are ineligible for cisplatin treatment.